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ABSTRACT: Myotonia congenita is an inherited disease that is characterized by impaired muscle relaxation after con-
traction caused by loss-of-function mutations in the skeletal muscle ClC-1 channel. We report a novel ClC-1 mutation,
T335N, that isassociatedwithamildphenotype in1patient, located in theextracellular I-J loop.Thepurposeof this study
was toprovide a solid correlationbetweenT335Ndysfunction and clinical symptoms in the affectedpatient aswell as to
offerhintsfordrugdevelopment.Ourmultidisciplinaryapproachincludespatch-clampelectrophysiologyonT335Nand
ClC-1wild-typechannelsexpressed in tsA201cells,Westernblot andquantitativePCRanalysesonmusclebiopsies from
patient and unaffected individuals, andmolecular dynamics simulations using a homology model of the ClC-1 dimer.
T335N channels display reduced chloride currents as a result of gating alterations rather than altered surface expression.
Molecular dynamics simulations suggest that the I-J loopmight be involved in conformational changes that occur at the
dimer interface, thusaffectinggating.Finally, thegeneexpressionprofileofT335Ncarriershowedadiverseexpressionof
K+ channel genes, compared with control individuals, as potentially contributing to the phenotype. This experimental
paradigm satisfactorily explainedmyotonia in the patient. Furthermore, it could be relevant to the study and therapy of
any channelopathy.—Imbrici, P., Altamura, C., Camerino, G.M.,Mangiatordi, G. F., Conte, E., Maggi, L., Brugnoni, R.,
Musaraj, K., Caloiero, R., Alberga, D., Marsano, R. M., Ricci, G., Siciliano, G., Nicolotti, O., Mora, M., Bernasconi, P.,
Desaphy, J.-F., Mantegazza, R., Camerino, D. C. Multidisciplinary study of a new ClC-1 mutation causing myotonia
congenita: a paradigm to understand and treat ion channelopathies. FASEB J. 30, 3285–3295 (2016). www.fasebj.org
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Myotonia congenita (MC), in its dominant and recessive
form, is the most common skeletal muscle ion channel-
opathy and is characterized by muscle stiffness after
voluntary effort (1). Usually, recessive MC has an early
age of onset and is more severe. Dominant MC encom-
passes a wider range of symptoms, from subclinical to
moderately severemanifestations (1, 2).MC is caused by
loss-of-function mutations in the CLCN1 gene that en-
codes the voltage-gated chloride channel, ClC-1, which
maintains the large shunting chloride conductance of
muscle fibers (3).
As for other ion channel diseases, functional studies
using heterologous expression systemshave beendecisive
to clarify molecular mechanisms underlying myotonia.
Indeed, in amajority of cases, biophysical characterization
of expressed ClC-1 mutants satisfactorily demonstrated
that specific ClC-1 defects were the obvious culprit for
clinical features of patients (4, 5). In vitro studies proved
that 2 recessive mutations must be present, each affecting
the function of 1 allele, to reduce chloride currents suffi-
ciently to producemyotonia (6, 7). In contrast, most ClC-1
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dominantmutants exert a dominant-negative effect on the
associated wild-type (WT) subunit in the heterodimeric
channel (8); however, in some cases, results of functional
studies of expressedmutant channelswere inadequate to
predict a clear correlation between genotype and clinical
symptoms, essential to define the most appropriate
treatment (9). For instance, myotonic individuals who
carry the same ClC-1 mutation can have markedly var-
iable expressivity (10). Some mutations may appear re-
cessive or dominant in different families, whereas others
show incomplete penetrance. Several recessive muta-
tions show no evidence of defective function in heterol-
ogous systems (5, 11, 12), and some dominantmutations
do not induce the expected dominant-negative effect on
theWT subunit (4–6). These evidences suggest that, as
in the case of other monogenic disorders, environ-
mental factors and genetic background of patientsmay
further contribute to variability of MC phenotype (10,
13). Thus, to fulfill the limits of heterologous expres-
sion, we recently studied muscle biopsies from pa-
tients with recessive MC to identify possible disease
modifiers among genes that are involved in muscle
excitability (11), demonstrating that biologic samples
from affected individuals can yield valuable informa-
tion for understanding of the myotonic phenotype.
Muscle biopsies can also help achieve a proper di-
agnosis of myotonia (14).
Another unsolved issue regarding myotonia, which is
common to a significant number of ion channelopathies, is
lack of a specific therapy.Myotonic patients are usually
administered symptomatic treatment, including mex-
iletine, a sodium channel blocker, or acetazolamide, a
carbonic anhydrase inhibitor, with limited side effects
and high percentages of nonresponders (15–17). Ab-
sence of direct ClC-1 opener prompts identification of
novel targets and development of new drugs. In this re-
spect, analysis of patients’ muscle biopsies, together with
pharmacologic studies on expressed channels, may sup-
port drug discovery. Furthermore, information about the
structure-function relationship of mutant channels, gained
from the molecular dynamics (MD) simulations of the 3-
dimensional (3D) structures of related CLC Cl2/H+ trans-
porters, may be precious for structure-function studies and
for rational design of ClC-1 ligands (5, 18–20).
Here, we report a novel CLCN1 variant, T335N, that is
associatedwith amild ThomsenMCphenotype identified
in one Italian patient. This mutation resides in the extra-
cellular I-J loop of theClC-1 protein,whose role in channel
function is unknown. We validated a multidisciplinary
approach that includes clinical, functional, and molecular
analyses by using heterologous expression of WT and
mutant ClC-1 channels as well as patient muscle biopsy
and MD simulations. Such study allowed us to compre-
hensively correlate the molecular and functional pheno-
typewithclinicalmanifestationsof theaffectedpatient and
to offer a solid starting point to address drug design and
therapy. Concerted application of different experimental
techniques is thus proposed as a promising paradigm for
in-depth understanding of disease mechanisms, which
may lead to personalized therapy of this and other ion
channelopathies.
MATERIALS AND METHODS
Mutagenesis and expression of hClC-1 WT and
mutant channels
The c.1004C.A mutation was introduced into the plasmid
pRcCMV-hClC-1 that contained the full-length WT hClC-1
cDNA by using the QuikChange site-directed mutagenesis kit
(Stratagene, Santa Clara, CA, USA), as previously described (5).
The complete coding region of the cDNA was sequenced to ex-
clude polymerase errors. tsA201 cells were transiently trans-
fected with a mixture of hClC-1 WT or T335N (5 mg) and CD8
reporter plasmids (1 mg) by using the calcium phosphate pre-
cipitation method. Only cells that were decorated with anti-CD8
antibody–coated microbeads (Dynabeads M450; Thermo Fisher
Scientific Life Sciences,Waltham,MA,USA)wereused forpatch-
clamp recordings.
Electrophysiology and data analysis
Standard whole-cell patch-clamp recordings were performed at
room temperature (;20°C) by using anAxopatch 200B amplifier
(Axon Instruments, Sunnyvale, CA, USA) (5). We measured the
I-V relationship and overall apparent open probability in high-
chloride (134 mM) intracellular solutions to enhance current
amplitude and inmore physiologic low internal chloride (4mM)
solutions. Composition of the extracellular solution was as fol-
lows (in mM): 140 NaCl, 4 KCl, 2 CaCl2, 1 MgCl2, and 5 HEPES,
pH 7.4 with NaOH. High-chloride pipette solution contained (in
mM): 130 CsCl, 2 MgCl2, 5 EGTA, and 10 HEPES, pH 7.4 with
CsOH. In this condition, cells were clamped at the holding po-
tential of 0 mV. In the low-chloride internal solution, cesium
chloride was substituted by cesium glutamate and cells were
clamped at the holding potential of –95mV. Pipetteswerepulled
from borosilicate glass and had ;2.5 MV resistance. Currents
were low-pass filtered at 2 kHzanddigitizedwith sampling rates
of 50 kHz by using theDigidata 1440AAD/DA converter (Axon
Instruments). In high-chloride solution, 400-ms voltage steps
were applied from2200mV to+150mV in 10-mV intervals, each
followed by a 100-ms voltage step at 2105 mV, where tail cur-
rents were measured. In low-chloride solution, currents were
elicited by 400-ms voltage steps between2150mVand +150mV
in 10-mV intervals, followed by a 100-ms test pulse to2105 mV
(5). Instantaneous and steady-state current–voltage relationships
were drawn by measuring instantaneous and steady-state cur-
rent densities (pA/pF) at the beginning (;1 ms) and at the end
(;390 ms) of each voltage step. Voltage-dependence of channel
activation was determined by plotting the apparent open proba-
bility (Po),obtainedfromnormalizedpeaktail currentsat2105mV,
as a function of the voltage of the preceding pulses (5). As sat-
uration of mutant currents at positive potentials was less pro-
nounced than that of WT, maximum current for normalization
was arbitrarily taken at +150 mV to calculate overall open
probability. Points were fitted with a Boltzmann function:
ðV Þ ¼ Pmin þ ðð12 PminÞÞ=f1þ exp½V2V0:5Þ=k g
where Pmin is the minimal value of Po, V0.5 is the half-maximal
activation potential, and k is the slope factor.
Open probability for slow gating (Po
slow) was obtained by
using a protocol similar to that for the overall Po (200 ms
conditioning pulse), except that an extra 400-ms activation
pulse to +180 mV was added before stepping to 2105 mV.
This very positive step fully activates the fast gates of the
channel and the tail currents at 2105 mV, then reflect only
slow gating (21). Apparent Po andPo
slowwere calculated from
normalized instantaneous current amplitude that was mea-
sured at the beginning of the tail pulse at 2105 mV. Because
overall apparent open probability equals the product of its fast
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and slow components, open probability of the fast gates
(Po
fast) was then calculated for a given test voltage by dividing
the relevant Po by its corresponding Po
slow. Voltage de-
pendence of channel activation was examined by plotting the
apparent open probability as a function of membrane poten-
tial and fitting data pointswith a Boltzmann function (5). Data
were analyzed by using pClamp 10.3 (Axon Instruments) and
SigmaPlotSoftware (Systat Software,Chicago, IL,USA).Results
are reported asmeans6 SEM from n cells, and statistical analysis
was performed by using Student’s t test, with P , 0.05 consid-
ered significant.
Quantitative real-time PCR analysis on
muscle biopsy
All gene expression experiments were performed as previously
described inPortaro et al. (11). Sectionsof humanmuscle biopsies
were snap frozen in liquidnitrogen soonafter removalandstored
at –80°C until use. For each muscle sample, total RNA was iso-
lated by an RNeasy Fibrous Tissue Mini Kit (Qiagen, Valencia,
CA,USA) andquantified byusing a spectrophotometer (Thermo
Fisher Scientific Life Sciences). RT and amplification were per-
formed byOvation PicoSLWTA systemV2 (NuGen, SanCarlos,
CA, USA). Real-time PCR was performed in triplicate by using
the Applied Biosystems real-time PCR 7500 Fast system (Foster
City, CA, USA). Each reaction was carried out in triplicate on a
single plex reaction. Results were compared with a relative
standardcurveobtainedby6points of 1:4 serialdilutions.mRNA
expression of different genes was normalized to the best house-
keepinggene,b-actin (ACTB), selected amongb-2microglobulin
(B2M), hypoxanthine phosphoribosyltransferase 1 (HPRT1), and
ACTB. ForKCNJ2,apoorly expressedgene, apreamplificationby
TaqMan PreAmpMaster Mix (Thermo Fisher Scientific Life Sci-
ences) was made before real-time experiments. Real-time PCR
experiments were performed in agreement with the MIQE
guidelines for quantitative PCR (qPCR), as published previously
(22). TaqMan Hydrolysis primer and probe gene expression as-
says IDs are detailed in the Supplemental Data.
Western blot analysis of muscle biopsies and
transfected cells
hClC-1 was isolated from muscle cells according to Papponen
et al. (23), with some modifications. In brief, human muscle bi-
opsies were homogenized in ice-cold buffer that contained
20 mM HEPES (pH 7.4), 2 mM EDTA, 0.2 mM EGTA, 0.3 M
sucrose, and 0.2 mM PMSF. Homogenates were centrifuged at
7000 g for 5 min at 4°C. Supernatant was centrifuged at 50,000 g
for 1 h at 4°C, and the pellet was solubilized in 20 ml of the same
buffer. tsA cells transfected with hClC-1 (10 mg) were harvested
in200ml of coldRIPAbuffer (150mMNaCl, 0.1%SDS, 1%NP-40,
0.5%Na deoxycholate, 100mMNa3VO3, 10mg/ml PMSF, and a
protease inhibitor cocktail) and incubated for 10 min in ice. To
complete cellular lysis, cell suspensions were passed through a
syringe with a needle 10 times. After 15 min of incubation in ice,
cell lysateswere centrifuged at 14,000 rpm for 30min at 4°C, and
supernatant was collected. Total protein amounts were quanti-
fiedbyusingaBradfordproteinassaykit (Bio-Rad,Hercules,CA,
USA). Proteins (40 mg from muscle biopsies; 1 mg from trans-
fected cells) were separated on a 4–12% SDS-PAGE and trans-
ferred onto nitrocellulosemembrane for 1 h at 200mA (SemiDry
transferblot; Bio-Rad).Membranewas blocked for 2 hwith 0.2M
Tris-HCl, 1.5 M NaCl, pH 7.4 buffer (TBS) that contained 5%
nonfat dry milk and 0.5% Tween-20 and incubated overnight at
4°Cwith rabbit anti–ClC-1 polyclonal antibody (c.n.MBS714620;
MyBiosource, San Diego, CA, USA) that was diluted 1:200 with
TBS that contained 5% nonfat drymilk. After 3 washes with TBS
that contained 0.5% Tween-20, membranewas incubated for 1 h
with goat anti-rabbit IgG conjugated to horseradish peroxidase
(Sigma-Aldrich, St. Louis, MO, USA). Membrane was then
washed with TBS with Tween-20, developed with a chemilu-
minescent substrate (Clarity Western ECL Substrate; Bio-Rad),
and visualized on a Chemidoc imaging system (Bio-Rad).
Biotinylation of cell-surface proteins
Cell-surface biotinylation was carried out with the Pierce Cell
Surface Protein Isolation Kit (Pierce, Rockford, IL, USA). tsA201
cells were transfected with pRcCMV-hClC-1, T335N, or both
constructs (10 mg each). One day after transfection, cell-surface
proteins were labeled with sulfosuccinimidyl-2-(biotinamido)
ethyl-1,3-dithiopropionate (Sulfo-NHS-SS-biotin). In brief, cells
were washed with ice-cold PBS twice, and Sulfo-NHS-SS-biotin
was added and incubated at 4°C, with constant rotation for
30 min. Excess biotin was quenched with quenching solution.
Cellswere treatedwith lysis buffer and centrifugedat 10,000 g for
2 min at 4°C. Clear supernatant was reacted with immobilized
NeutrAvidin gel slurry in columns to isolate surface proteins.
Columns were washed and protein eluted in sample buffer that
containedDTT. Surface proteinswere separated on a SDS-PAGE
gel, and samples (1mg)were analyzed byWestern blotting using
a monoclonal anti–ClC-1 antibody (MyBiosource). Filters were
also immunoblotted with b-actin monoclonal antibody (Sigma-
Aldrich) as control. Total proteindensitywas standardizedas the
ratio of input signal to b-actin signal, normalized to WT control.
Surface protein density was measured as the ratio of surface
signal to cognate total b-actin signal, followed by normalization
to WT control.
Molecular dynamics
The homologymodel of ClC-1, recently published by Bennetts
and Parker (24), was used as initial structure. It consists of the
ClC-1 dimer that is based on the crystallographic coordinates
of CmClC [Protein Data Bank (PDB) ID 3ORG; http://www.
rcsb.org/pdb/] (19). Following the protocol of a recent work (5),
we excluded from the model the C-terminal (from residue 588).
This enabled us to perform 2 independent longMD simulations
(2 3 50 ns) for each investigated system with a reasonable
computational time. As a first step, we pretreated the resulting
structure by using the protein preparation wizard (version 9.5;
Shro¨dinger, New York, NY, USA) (25). Simulation system was
built as follows: A 1103 140 A˚2 POPC (1-palmitoyl,2-oleoyl-sn-
glycero-3phosphocholine) bilayer patch was first built by using
themembrane plugin of visualmolecular dynamics (VMD) (26),
with the membrane normal along the z axis. ClC-1 dimer was
embedded in this bilayer, and lipid molecules within 0.6 A˚ of
heavy atoms of the protein were removed. To neutralize the
system, 47 Na+ and 65 Cl2 ions were added using the VMD
autoionize plugin, generating a 150-mM ionic concentration and
a final systemof136,784atoms (number computed forWT). Two
different protein structures were built, the WT form and the
mutated T335N form. The latter was obtained by using the
mutator plugin available in VMD. Both T335N andWT protein
structures were incorporated into a periodic box of TIP3P water
molecules (27) that was extended by 18 A˚ in each direction
from all protein atoms by using the Add Solvation Box plugin
of VMD. All MD simulations were performed using NAMD
2.9 (28) and the CHARMM27 force field (29). Note that the
useConstantArea option was set to on to keep realistic lipid
structures. The full system was minimized to remove steric
clashes in the initial geometry andwas gradually heated up to
310 K within 500 ps of MD. SHAKE algorithm was employed
to constrain all R–H bonds (30). Rigid water molecules were
implemented by using the SETTLE algorithm (31). Peri-
odic boundary conditions were applied in all directions. A
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nonbonded cutoff of 12 A˚ was used, whereas the Particle-
Mesh-Ewald (32) was employed to include contributions of
long-range interactions. All simulationswere performed in an
isothermal-isobaric ensemble (1 atm, 310 K) with a modified
Nose´–Hoover method in which Langevin dynamics was used
to control fluctuations in the barostat, as implemented in
NAMD 2.9 (33) (oscillation period, 200 fs; decay coefficient,
100 fs), and a Langevin thermostat (34) (damping coefficient,
1 ps21). Time step was set to 2 fs, and coordinates were saved
every 5000 steps (10 ps). Two MD trajectories of 50 ns were
obtained for both the WT and the mutated T335N form. For
each investigated system, equilibration of the structure re-
quired ,5 ns and, thus, we removed the early 5 ns from
analysis. To visualize the ClC-1 3D structure and the position
of the mutated residue, the homologymodel was rendered by
using PyMOL (Shro¨dinger).
RESULTS
Clinical phenotype
A single c.1004C.A mutation in exon 9 of the CLCN1
gene, corresponding top.T335Namino acid substitution in
ClC-1,was detected in one Italian patient. The proband is a
43-yr-oldmalewhopresented at age 15 yrwith lower-limb
muscle stiffness, sometimes painful and mainly occurring
at the beginning of movement after prolonged rest and
improvingwithexercise.Thepatienthasnever complained
of cold-aggravated myotonia or transient weakness. Neu-
rologic examination revealed myotonia with warm-up,
mainly in quadriceps without muscle weakness or hyper-
trophy. Electromyography showedmyotonic discharges
in all investigated muscles. Symptoms remained stable
over the years without any relevant limitation in daily
activities. The patient has never taken any treatment for
myotonia. Except for absence of muscle hypertrophy,
clinical phenotype was compatible with Thomsen dis-
ease. Family history was negative.
Functional analysis of T335N channels
expressed in tsA201 cells
Mutation T335N is associated with a mild Thomsen
phenotype and resides in the extracellular loop that
connects helices I and J (Supplemental Fig. 1). To test
whether this conserved amino-acidic variant altered
ClC-1 permeation and gating to cause myotonia in the
patient, we transfected tsA201 cells with equal amounts
of WT or T335N cDNA and analyzed chloride currents
bywhole-cell patch-clamp. As shown in Fig. 1A, in high
intracellular chloride solution, T335N homodimeric
channels showed a gating behavior very different from
that of WT. Indeed, T335N currents activated slowly at
hyperpolarized potentials and lacked fast deactiva-
tion typical of WT ClC-1 currents. Instantaneous and
steady-state current densities for T335N were reduced
at each voltage compared with WT (Fig. 1B, C and
Table 1). The attempt to fit normalized tail currents as a
function of voltage with a Boltzmann function revealed
an ;160 mV rightward shift of voltage-dependent ac-
tivation for T335Nwith respect toWT (Fig. 2A,B,D and
Table 1). As hClC-1 is a dimer formed by 2 identical
subunits that open and close through a fast or slow
gating pattern (21), we also analyzed the effect of the
T335N mutation on the open probability for fast and
slow gating. Of interest, voltage dependence for slow
gating was shifted by about ;160 mV in the positive
direction,whereas fast gatingwas abrogated (Fig. 2B, E, F
and Table 2).
To have a clearer picture of the functional behavior
of homomeric T335N channels, the same biophysical
characterization was performed under more physio-
logic recording conditions. Of note, in low intracellular
chloride solution, hyperpolarization-induced activa-
tion was abolished, current was significantly reduced,
and Po was right shifted for T335N compared withWT
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Figure 1. Current amplitude for hClC-1 WT,
T335N, and WT + T335N channels in high
intracellular chloride. A) Representative chlo-
ride currents recorded from tsA cells transfected
with hClC-1 WT (5 mg), T335N (5 mg), or with
equal amount of WT and T335N (5 mg + 5 mg)
cDNAs in high-chloride intracellular solution.
B) Instantaneous currents were normalized with
respect to cell capacitance (pA/pF) and report-
ed as a function of voltage. C) Steady-state currents
were reported as mean current density as a
function of voltage. Solid lines represent WT
currents; dashed line represents the algebraic
sum of current densities calculated for WT and
T335N expressed alone. Each point is mean 6
SEM from 13–18 cells.
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channels (Supplemental Fig. 2A–C and Table 1), cor-
roborating previous results.
As the affected patient carries 1 normal and 1 mu-
tated CLCN1 allele, the major contribution to total
chloride current is plausibly represented by hetero-
dimeric WT + T335N channels, assuming that WT and
T335N subunits are equally expressed. Thus, to better
reproduce in vitro this heterozygous condition, we
coexpressed T335N with equal amounts of WT cDNA
in tsA cells. Of interest, in high-chloride solution,WT +
T335N channels showed gating properties similar
to WT, with both inwardly and outwardly rectifying
currents but without the hyperpolarization-activated
component (Fig. 1A). The steady-state current density
of heteromeric channels was, at each voltage, less
than half of that of homomeric WT channels (Fig. 1C).
In addition, total Po was shifted by ;30 mV toward
more positive potentials compared with respectiveWT
homomeric channels (Fig. 2C, D and Table 1), so that
WT + T335N channels were less likely to be open in the
physiologic voltage range. Separation of common and
fast gating revealed that voltage dependence for slow
and fast gating was significantly shifted by approxi-
mately +40 and +10 mV, respectively (Fig. 2E, F and
Table 2). Of interest, patch-clamp recordings of WT +
T335N channels carried out in low-chloride intra-
cellular solution confirmed biophysical alterations ob-
served in high intracellular chloride solution. Indeed,
TABLE 1. Biophysical parameters for hClC-1 WT, T335N, and WT + T335N channels
ClC-1 [Cl2] (mM) V0.5 Po
total[mV (k)] Pmin
total IC (pA/pF) SSC (pA/pF) Cells (n)
WT 134 274 6 1 (30 6 1) 0.45 6 0.04 272 6 6.7 50.5 6 6 15
T335N 134 94 6 5* (25 6 2) 0.68 6 0.06 213 6 2.9* 7.6 6 2.2* 13
WT + T335N 134 250 6 3 (51 6 2) 0.39 6 0.03 259 6 6 31 6 3.8 18
WT 4 222.9 6 1.3 (37 6 1) 0.23 6 0.03 — 35 6 8.9 8
T335N 4 39.1 6 4.4 (72 6 5)* 0.45 6 0.03* — 5.8 6 1* 10
WT + T335N 4 30.1 6 6.7 (74 6 8)* 0.17 6 0.03 — 17.9 6 6.3* 7
Data are means 6 SEM of the indicated number of cells. V0.5, half maximal activation potential; k, slope factor; Pmin, minimal value of Po measured
at 290 mV; IC, instantaneous current measured at 260 mV; SSC, steady state current measured at +60 mV. *P , 0.05 compared with WT.
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Figure 2. Open probability for hClC-1 WT, T335N, and WT + T335N hClC-1 channels in high intracellular chloride. A–C)
Representative tail current traces elicited from tsA cells transfected with WT (A), T335N (B), and WT+T335N (C) from
experiments to determine overall gating (top) and slow gating (bottom) in high intracellular chloride solution. D–F) Apparent
Po for overall (D), slow (E), and fast gating (F) plotted as a function of test voltage, for WT, T335N, and WT + T335N channels.
Relationships obtained from averaged data were fit with a Boltzmann equation. Solid lines represent the WT currents. Open
probability for slow gating was obtained as described in Supplemental Data. Fit parameters are reported in Tables 1 and 2. Each
point is mean 6 SEM from 7–11 cells.
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we detected a positive shift ofWT + T335N total Po and a
dramatic reduction of steady-state current compared
with homomeric WT channels (Supplemental Fig. 2A–C
and Table 1). This dominant effect of the mutant on the
WT subunit reasonably contributed to the decline in
sarcolemmal gCl in the affected carrier.
Reduction of chloride current observed when mutant
channels were expressed in tsA cells could be accounted
for by an alteration of gating and/or by a reduction in the
number of functional channels in the plasma membrane.
Thus, to investigate the membrane trafficking property of
T335N channels, we performed protein biotinylation as-
say on cells that expressed WT, T335N, and WT + T335N
channels.Figure 3A shows thatT335Nchannels displayed
cell-surface expression similar to that of WT. In addition,
coexpression of T335N withWT did not affect membrane
trafficking of ClC-1 channels.
Western blot and quantitative analysis of
gene expression in muscle biopsy of patient
with T335N
To study T335N channel properties in a more physiologic
setting, we next evaluated the amount of total ClC-1 pro-
teins extracted from vastus lateralis muscle biopsies of the
T335N carrier and of 4 control individuals. As shown in
Fig. 3B, Western blot analysis revealed that total ClC-1
protein amount was similar in controls as well as in the
affected patient, which reasonably excluded that alter-
ations in ClC-1 protein synthesis as a result of T335N
mutation may contribute to myotonia and supported re-
sults obtained from transfected cells.
To assess whether a variation in expression of other
genes could further concur to clinical phenotype of the
patient and to identify potential drug targets, we next
performed a quantitative real-time PCR analysis of a
number of gene transcripts from the samemuscle biopsy
of the proband and compared results with 6 controls of
the same gender and age. Genes under investigation
encoded for sarcolemmal ion channels and transporters
that are involved in action potential generation and
propagationor in calciumhomeostasis, and/orhavebeen
linked to skeletal muscle excitability disorders (Supple-
mental Table 1). In agreementwithWestern blot analysis,
quantitative PCR analysis showed that the amount of
ClC-1 T335N mRNA was within range of control indi-
viduals (Fig. 3C). Furthermore, we observed no substan-
tialdifferences between themyotonicpatient andcontrols
in the amount of ion channel transcripts, such as voltage-
dependent Na+ channel hNav1.4 (SCN4A), Na+ channel
b1 subunit (SCN1B), large-conductance Ca2+-activated
K+ channel (KCNMA1, Slo1), voltage-dependent K+
channel Kv3.4 (KCNC4), ATP-sensitive, inward rectifier
K+ (KATP) channel Kir6.2 (KCNJ11), sulfonylurea re-
ceptor type 2A (SUR2A protein, ABCC9 gene), 2 in-
ward rectifier K+ channels, Kir2.1 (KCNJ2) and Kir2.6
(KCNJ18), Na+/K+- ATPase (ATP1A2), and Ca2+ chan-
nel Cav1.1 (CACNA1S). The most interesting observa-
tion, to be confirmed in other myotonic cases, was
the presence of the transcript of MinK-related peptide
2 (KCNE3) in this dominant MC biopsy (Fig. 3C) that
was reported instead to be absent in 2 biopsies of pa-
tients with recessive MC (11). In addition, we observed
a greater amount of mRNA that encoded the small-
conductance Ca2+-activated K+ channel (KCNN3) in the
affected patient with respect to controls.
MD simulations of WT and T335N channels
T335N mutation is located in an extracellular loop that
connects helix I and helix J, close to the interface between
the 2 monomers (Fig. 4A). To provide a putative mo-
lecular explanation for the gating alteration induced by
T335N, we carried out an in-depth analysis of obtained
MD trajectories for WT and T335N channels. As a first
step,we analyzed hydrogen-bond (H-bond) interactions
that occurred in the dimer within simulated trajectories,
an approach already proven to give valuable insight into
the gatingmechanisms ofClC-1 andother proteins (5, 35,
36). Of interest, the sole appreciable difference was ob-
served for the extracellular loop that connected helices P
and Q, namely, the protein segment from residue in
position 551 to that in position 555 (Fig. 4A). Suchprotein
portion, which is located close to the loop where muta-
tion takes place, is responsible for intermonomeric in-
teractions at the extracellular side of the dimer. Rate of
occurrence (percent) of intermonomeric H-bonds that
involve such loop during the entire analyzed trajectories
is reported inTable 3 and shows the percentage of frames
in which a given H-bond is formed, using as thresholds a
distance between atom acceptor (AA) and atom donor
(AD) equal to 3 A˚ and an angle AD-H–AA equal to 150°.
All possible interactions between monomer A and B in-
volved residues Q552 and I553. We observed that the
occurrence of such H-bond interactions was far less fre-
quent after mutating the threonine residue in position
335. Of importance, such a trend is observed to account
for both analyzed independent trajectories. A meaning-
ful example is given by H-bond interaction that occurrs
between Q552 and I553, whose percentage of formation
TABLE 2. Open probability for slow and fast gating for hClC-1 WT, T335N, and WT + T335N channels in high-chloride solution
ClC-1 V0.5 Po
slow[mV (k)] Pmin
slow V0.5 Po
fast[mV (k)] Pmin
fast Cells (n)
WT 279 6 2 (31 6 1) 0.69 6 0.03 287 6 1 (27 6 1) 0.64 6 0.04 10
T335N 90 6 7 (31 6 3)* 0.78 6 0.05 — 0.89 6 0.07 7
WT + T335N 240 6 4 (58 6 3)* 0.53 6 0.03 276 6 1 (18 6 1) 0.72 6 0.02 11
Data are means 6 SEM of the indicated number of cells. V0.5, half maximal activation potential; k, slope factor; Pmin, minimal value of
Po measured at 290 mV; Po
fast, open probability of the fast gate; Po
slow, open probability of the slow gate. *P , 0.05 compared with WT.
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drops down from 16.24% (WT 1, first simulation of WT
form) and 16.16% (WT 2, second simulation ofWT form)
to 0.02% (T335N 1) and 0.00% (T335N 2). Undoubtedly,
such H-bond was forthwith lost during MD simulations
of T335N. For clarity, Fig. 4B shows representative MD
snapshots that indicate the residues engaged in this
H-bond interaction. As shown in Fig. 4B, H-bond inter-
actions could facilitatemolecular interplay between the 2
monomers by increasing their proximity. Such a differ-
ent behavior between WT and T335N was also clearly
confirmed by the time dependence of the distance be-
tween theH-bonddonor andH-bondacceptor side chain
atoms of B-Q552 and A-I553 interaction (Fig. 4C). Of
importance, distance values, which are compatible with
H-bond interaction,were never experiencedduring the 2
simulations of T335N. On the contrary, this interaction
occurred frequently during both simulations ofWT and,
whenever lost, it was re-established after a few nano-
seconds. This strongly supported the robustness of the
molecular hypothesis that resulted from analysis of the
occupancies (Table 3): the replacement of a threonine
with a asparagine in position 335 in the I-J loop could
alter the intermonomeric interactions that involved the
extracellular loop that connects helices P and Q.
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Figure 3. Quantification of protein amounts and analysis of gene expression. A) Western blot of total and surface ClC-1 and
b-actin proteins from tsA cells transfected with equal amounts of WT (10 mg), T335N (10 mg), and WT + T335N (5 mg + 5 mg;
top) and quantification of total and surface proteins normalized to WT (bottom). Each bar is mean6 SEM from 3 experiments. B)
Western blot (top) and quantification (bottom) of total ClC-1 and b-actin proteins in muscle tissue from 4 control individuals
(CTRLs) and T335N patient. C) Quantitative gene expression of selected ion channels and transporters from vastus lateralis
muscle biopsies of control individuals and T335N patient. For each gene, box plot encloses 50% of data from 6 controls, with the
median value displayed as a line. Closed circles represent T335N; top and bottom of the box mark the limits of 625% of the
range of data; lines extending from the top and bottom of each box mark the minimum and maximum values within the data set
that fall within an acceptable range. Data are means of triplicate measures.
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DISCUSSION
Here, we performed an in-depth genotype-phenotype
correlation of a novel case of MC in which the patient
carried the T335N mutation, and we have attempted to
provide suggestions for drug development by using a
coherent and multidisciplinary experimental plan.
T335N ClC-1 mutation promotes effects on
channel gating that explain myotonia
Patch-clamp recordings of homomeric and hetero-
meric T335N channels expressed in tsA cells revealed
pronounced changes in voltage-dependent gating com-
pared with WT. Indeed, both in high- and low-chloride
intracellular solutions,homomericT335Nchannels showed
dramatically reduced current density, together with a
positive shift of voltage dependence of activation. Of
importance, chloride currents produced by spontaneous
assembly of T335N and WT subunits were smaller than
those of WT alone, which indicated a dominant effect of
T335N on the WT subunit—an effect typical of most
dominant mutations (9). Actually, surface expression of
T335N proteins was comparable to that of WT channels
alone and T335N subunit did not affect membrane
transport of coexpressed WT subunits. To substantiate
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Figure 4. Visual inspection of the ClC-1 homology model and analysis of H-bond interactions. A) Top view of the homology
model. Atoms belonging to residue T335 and to loop P-Q are rendered as sticks, whereas the ClC-1 dimer is shown in cartoon
representation. B) Enlarged monomers are depicted in cartoon representation, whereas important residues are shown as sticks.
H-bond interaction is depicted by a dotted line. C) Time-dependent evolutions of the distance between the nitrogen donor of the
side chain of B-Q552 and the oxygen atom of the A-I553 backbone resulting from 2 independent MD simulations of WT (red and
black lines) and T335N (blue and green lines).
TABLE 3. Analysis of H-bond interactions
H-bond Occupancy (%)
Donor Acceptor WT 1 WT 2 T335N 1 T335N 2
B-Q552 side A-I553 backbone 16.24 16.16 0.02 0.00
A-Q552 side B-Q552 side 4.64 5.49 2.20 0.64
B-Q552 side A-Q552 side 3.80 9.24 0.36 0.02
A-I553 backbone B-Q552 side 5.89 0.00 0.02 0.00
Computed occupancies (%) of the H-bonds occurring between the 2 monomers (A and B) and
involving the P-Q loop. An AD–AA distance equal to 3 A˚ and an angle AD-H–AA equal to 150° were used
as thresholds to define the presence of the H-bond.
3292 Vol. 30 October 2016 IMBRICI ET AL.The FASEB Journal x www.fasebj.org
Downloaded from www.fasebj.org by (131.114.70.49) on December 11, 2019. The FASEB Journal Vol. ${article.issue.getVolume()}, No. ${article.issue.getIssueNumber()}, pp. 3285-3295.
these biophysical and biochemical data from trans-
fected cells and better explain the clinical phenotype in a
more physiologic and reliable setting, we used the
available biopsy from the vastus lateralis muscle of the
patient to perform gene and protein expression analy-
ses. Of interest, the amount of ClC-1mRNAand protein
detected in the bioptic sample of the T335N carrier was
comparable to that of controls. Thus, combination of the
biophysical characterization of mutant channels with
molecular data obtained from transfected cells and pa-
tient biopsy allowed us to reasonably conclude that
gating dysfunction of mutant ClC-1 channels might be
the principal cause of reduced chloride current and
consequent myotonia in this patient.
Variable expression of ion channel genes
in MC
As with many genetic disorders, range of symptoms
associated with myotonia might result from interplay
of different genes and life conditions that act as dis-
ease modifiers (11, 37–41). Muscular dystrophy, sodium
channel myotonia, and several forms of idiopathic epi-
lepsies, for example, are associated with variable out-
comes that arise from both primary genetic mutation
and contribution of environmental and genetic modi-
fiers (37–39) that can influence penetrance, age of onset,
progression, or severity of disease (41). In the case ofMC,
gene expression quantification on muscle biopsies of
affected and control individuals could be a valuable and
innovative approach for identification of suchmodifiers.
Indeed, in a recent study, quantitative PCR analysis of
muscle biopsies from 2 patients who suffered a severe
Becker phenotype showed a greater expression of the
sodium channelb1 accessory subunit (SCN1B) and total
lack of the Kv3.4 potassium channel accessory subunit
MinK-related peptide 2 (KCNE3) (11). Surprisingly, the
amount of KCNE3 and KCNN3 transcripts in the
available Thomsen T335Nmyotonic muscle fell outside
the ranges quantified for control individuals. Although
quantification of ion channel transcriptswas performed
in only 1 patient with MC, these results led us to spec-
ulate that increased expression of KCNE3 and KCNN3
mightmodulate themyotonic phenotype in this patient.
Neurophysiologic examination of the T335N patient,
indeed, reported only mild clinical myotonic signs that
do not interfere with everyday life activities. It is worth
noting that the poor number of human samples ana-
lyzed to date does not allow us to draw a definitive
conclusion, and quantitative PCR screening on a larger
number of cases is required to validate these results. If
confirmed in other patients, these data from muscle
biopsies might also suggest alternative pharmacologic
targets in myotonia (11). Indeed, proper stimulation of
K+ currents to compensate for reduced chloride con-
ductance may be explored for treatment of MC. Ac-
cordingly, activation of K+ currents after carbonic
anhydrase inhibition provided a sound explanation for
the beneficial action of acetazolamide and its deriva-
tives, which, until now, have been usedonly empirically
as antimyotonic drugs (42).
Structural insight into I-J loop involvement in
ClC-1 channel function
Biophysical characterization of naturally occurring muta-
tions in ion channels, together with availability of high-
resolution 3D structures of these proteins, can provide
relevant information about their structure-function re-
lationship. This, in turn, is pivotal for addressing selective
drugdesign. In thecaseofT335Nmutation, residueT335 is
located in the extracellular I-J loop of ClC-1, whose con-
tribution to ClC-1 activity has never been investigated
before. From visual inspection of the 3D structure of ClC-
1dimers, this loop connects the 2 antiparallel halves (B–I
and J–Q) of aClC-1monomer (18) andmakes contactwith
the extracellular P-Q loop, which is responsible for inter-
actions between the 2 monomers at the extracellular side.
Consistently, the dominant-negative effect of the T335N
subunit on the WT observed in patch-clamp experiments
also suggests that the I-J loop may affect intermonomeric
interactions at the dimer interface (8, 43). Moreover, one
peculiar characteristic of T335N homomeric channels in
high-chloride solution was the unusual current activation
at negative potentials, together with a disruption of fast
and slow gating, whose physiologic significance and mo-
lecular mechanism are as yet unclear. In this context,
combination of MD simulations and electrophysiology
elucidated atmolecular levels both the functional defect of
T335N channels and the role of the I-J loop in ClC-1
channel function. Of note, analysis of MD trajectories of
homomeric T335N and WT channels actually demon-
strated that the I-J loop might remotely control confor-
mational changes that occur at the boundary region
between 2 monomers. In particular, occurrence of the
T335Nmutation in the I-J loop causes aweakening of the
H-bond interaction between residues Q552 and I553 of
the P-Q loop of 2 distinct monomers. One possible in-
terpretative hypothesis couldbe that, as a consequence of
this impaired interaction between the 2 T335N subunits,
chloride currents lose fast deactivation at negative po-
tentials that is typical of ClC-1 WT channels observed in
patch-clamp recordings of T335N channels. Of interest, a
hyperpolarization-activated gating, which occurs via a
cooperative conformational changeof 2mutant subunits,
has been previously shown for other heterozygous MC
mutations, including Q552R of loop P-Q (44–48). Thus,
similar to T335N, activation at negative voltages of
Q552R homomers could likely be ascribed to disruption
of the intermonomeric H-bond between Q552 and I553.
As T335N channels impaired fast and slow gates, we
may also hypothesize that the I-J loop might take part in
complex conformational rearrangements that contribute
to these gating processes (5, 24, 49, 50). In agreement with
the relevance of the I-J loop in ClC-1 activity, it is worth
reporting that this loop is involved in the mechanism that
underlies niflumic acid and Ca2+ potentiation of kidney
ClC-K currents (51). Thus, at least in ClC-K channels, this
loopmight also represent an ideal target for drugs that are
aimed at increasing chloride currents. Given the structural
similarity within the CLC family (18), it would be ap-
pealing to employ such results for addressing the rational
design of ClC-1 opener.
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In summary, patch-clamp studies of ClC-1 mutants
demonstrated that T335N exerts a dominant effect on the
WT subunit that likely accounts for myotonia. MD simu-
lations support the electrophysiologic data and envisage
the role of the I-J loop in channel gating and modulation
after intermonomeric interactions. Quantitative analyses
ofgeneexpression in this andprevious studies (11) suggest
that variations in expression of K+ channel genes might
contribute to the myotonic phenotype and offer novel
druggable targets. This multidisciplinary approach, here
validated for MC, could be extended to other channelo-
pathies to allow a better understanding of these disorders
and to build the basis for personalized therapy.
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